Company · CIK 0001437402 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ARDELYX, INC. · ARDX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 18, 2016 PForm 4 → | Jul 20, 4:40 pm EDT | Krishna Kittu Kolluri10% Owner | 2,290,951 | $8.73 | $20,000,002 | 2,665,519 | +612% | plan? |
| Jul 18, 2016 PForm 4 → | Jul 20, 4:40 pm EDT | Patrick J Kerins10% Owner | 763,650 | $8.73 | $6,666,665 | 8,752,543 | +9.56% | plan? |
| Jul 18, 2016 PForm 4 → | Jul 20, 4:39 pm EDT | Anthony A. Florence Jr.10% Owner | 1,527,301 | $8.73 | $13,333,338 | 2,665,519 | +134% | plan? |
| Jul 18, 2016 PForm 4 → | Jul 20, 4:39 pm EDT | Forest Baskett10% Owner | 2,290,951 | $8.73 | $20,000,002 | 2,665,519 | +612% | plan? |
| Jul 18, 2016 PForm 4 → | Jul 20, 4:38 pm EDT | Peter J Barris10% Owner | 2,290,951 | $8.73 | $20,000,002 | 2,665,519 | +612% | plan? |
| Jul 18, 2016 PForm 4 → | Jul 20, 4:38 pm EDT | M James Barrett10% Owner | 763,650 | $8.73 | $6,666,665 | 8,752,543 | +9.56% | plan? |
| Jul 18, 2016 PForm 4 → | Jul 20, 4:37 pm EDT | New Enterprise Associates 12, Limited Partnership +210% Owner | 763,650 | $8.73 | $6,666,665 | 8,752,543 | +9.56% | plan? |
| Jul 18, 2016 PForm 4 → | Jul 20, 4:36 pm EDT | NEA 15 GP, LLC10% Owner | 1,527,301 | $8.73 | $13,333,338 | 2,665,519 | +134% | plan? |
| Jun 2, 2016 AForm 4 → | Jun 6, 7:46 pm EDT | David M MottDirector, 10% Owner | 8,522 | — | — | 14,343 | — | plan? |
| Jun 2, 2016 AForm 4 → | Jun 6, 7:36 pm EDT | William C Bertrand Jr.Director | 4,854 | — | — | 9,854 | — | plan? |
| Jun 2, 2016 AForm 4 → | Jun 6, 7:35 pm EDT | Richard J RodgersDirector | 6,742 | — | — | 11,296 | — | plan? |
| Mar 21, 2016 PForm 4 → | Mar 21, 7:31 pm EDT | Gordon RingoldDirector | 15,000 | $7.77 | $116,540 | 15,000 | — | plan? |
| Mar 3, 2016 SForm 4 → | Mar 7, 9:15 pm EST | David P. RosenbaumSVP, Drug Development | 1,128 | $10.74 | $12,110 | 22,144 | −4.85% | plan? |
| Feb 16, 2016 SForm 4 → | Feb 18, 6:35 pm EST | Mark KaufmannChief Financial Officer | 5,000 | $10.25 | $51,272 | 1,282 | −79.6% | plan? |
| Feb 16, 2016 MForm 4 → | Feb 18, 6:35 pm EST | Mark KaufmannChief Financial Officer | 5,000 | $0.54 | $2,700 | 6,282 | — | plan? |
| Jan 13, 2016 PForm 4 → | Jan 15, 9:01 am EST | Jon Sakoda10% Owner | 1,000,000 | $10.00 | $10,000,000 | 1,901,869 | +111% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:33 pm EST | Harry R Weller10% Owner | 1,000,000 | $10.00 | $10,000,000 | 1,901,869 | +111% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:32 pm EST | Ravi Viswanathan10% Owner | 1,000,000 | $10.00 | $10,000,000 | 1,901,869 | +111% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:32 pm EST | Peter W. Sonsini10% Owner | 1,000,000 | $10.00 | $10,000,000 | 1,901,869 | +111% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:31 pm EST | Scott D Sandell10% Owner | 1,500,000 | $10.00 | $15,000,000 | 1,901,869 | +373% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:30 pm EST | David M MottDirector, 10% Owner | 1,000,000 | $10.00 | $10,000,000 | 1,901,869 | +111% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:30 pm EST | Joshua Makower10% Owner | 1,000,000 | $10.00 | $10,000,000 | 1,901,869 | +111% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:29 pm EST | Krishna Kittu Kolluri10% Owner | 1,500,000 | $10.00 | $15,000,000 | 1,901,869 | +373% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:29 pm EST | Patrick J Kerins10% Owner | 500,000 | $10.00 | $5,000,000 | 7,988,893 | +6.68% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:28 pm EST | Anthony A. Florence Jr.10% Owner | 1,000,000 | $10.00 | $10,000,000 | 1,901,869 | +111% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:28 pm EST | Forest Baskett10% Owner | 1,500,000 | $10.00 | $15,000,000 | 1,901,869 | +373% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:27 pm EST | Peter J Barris10% Owner | 1,500,000 | $10.00 | $15,000,000 | 1,901,869 | +373% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:26 pm EST | M James Barrett10% Owner | 500,000 | $10.00 | $5,000,000 | 7,988,893 | +6.68% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:26 pm EST | New Enterprise Associates 12, Limited Partnership +210% Owner | 500,000 | $10.00 | $5,000,000 | 7,988,893 | +6.68% | plan? |
| Jan 13, 2016 PForm 4 → | Jan 14, 4:25 pm EST | NEA 15 GP, LLC10% Owner | 1,000,000 | $10.00 | $10,000,000 | 1,901,869 | +111% | plan? |
| Jan 5, 2016 AForm 4 → | Jan 7, 6:46 pm EST | Paul KornerEVP, Chief Medical Officer | 60,753 | — | — | 60,753 | — | plan? |
| Dec 17, 2015 PForm 4 → | Dec 21, 9:35 pm EST | William C Bertrand Jr.Director | 5,000 | $20.00 | $100,000 | 5,000 | — | plan? |
| Dec 15, 2015 SForm 4 → | Dec 17, 5:12 pm EST | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $20.00 | $40,000 | 47,420 | −4.05% | plan? |
| Dec 15, 2015 MForm 4 → | Dec 17, 5:12 pm EST | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $0.54 | $1,080 | 49,420 | — | plan? |
| Dec 15, 2015 JForm 4 → | Dec 17, 4:54 pm EST | Presidio Partners 2007, L.P. +110% Owner | 300,000 | — | — | 63,490 | — | plan? |
| Nov 27, 2015 SForm 4 → | Dec 1, 5:21 pm EST | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $20.00 | $40,000 | 47,420 | −4.05% | plan? |
| Nov 27, 2015 MForm 4 → | Dec 1, 5:21 pm EST | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $0.54 | $1,080 | 49,420 | — | plan? |
| Oct 8, 2015 SForm 4 → | Oct 13, 5:01 pm EDT | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $19.88 | $39,760 | 47,420 | −4.05% | plan? late |
| Oct 8, 2015 MForm 4 → | Oct 13, 5:01 pm EDT | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $0.54 | $1,080 | 49,420 | — | plan? late |
| Sep 21, 2015 SForm 4/A → | Mar 7, 2016, 9:14 pm EST | David P. RosenbaumSVP, Drug Development | 1,400 | $22.05 | $30,874 | 21,940 | −6.00% | plan? |
| Sep 21, 2015 SForm 4 → | Sep 23, 5:39 pm EDT | David P. RosenbaumSVP, Drug Development | 1,400 | $22.05 | $30,874 | 73,652 | −1.87% | plan? amended |
| Sep 15, 2015 SForm 4/A → | Mar 7, 2016, 9:13 pm EST | David P. RosenbaumSVP, Drug Development | 2,540 | $22.01 | $55,898 | 23,340 | −9.81% | plan? |
| Sep 15, 2015 SForm 4 → | Sep 17, 5:02 pm EDT | David P. RosenbaumSVP, Drug Development | 2,540 | $22.01 | $55,898 | 75,052 | −3.27% | plan? amended |
| Sep 10, 2015 SForm 4 → | Sep 11, 7:53 pm EDT | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $20.59 | $41,185 | 47,420 | −4.05% | plan? |
| Sep 10, 2015 MForm 4 → | Sep 11, 7:53 pm EDT | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $0.54 | $1,080 | 49,420 | — | plan? |
| Sep 8, 2015 SForm 4 → | Sep 10, 4:57 pm EDT | Michael RaabPresident & CEO, Director | 9,785 | $20.29 | $198,544 | 70,385 | −12.2% | plan? |
| Sep 1, 2015 SForm 4 → | Sep 3, 5:42 pm EDT | David P. RosenbaumSVP, Drug Development | 2,537 | $18.78 | $47,641 | 25,880 | −8.93% | plan? |
| Sep 1, 2015 SForm 4 → | Sep 3, 5:41 pm EDT | Jeremy S CaldwellEVP, Chief Scientific Officer | 643 | $18.32 | $11,780 | 0 | −100% | plan? |
| Sep 1, 2015 SForm 4 → | Sep 3, 5:41 pm EDT | Elizabeth A GrammerVP, General Counsel | 893 | $18.32 | $16,360 | 0 | −100% | plan? |
| Aug 31, 2015 AForm 4 → | Jan 20, 2016, 7:19 pm EST | Narani ArasaratnamVP, Corporate Controller | 1,232 | $13.99 | $17,237 | 1,232 | — | plan? late |
| Aug 31, 2015 AForm 4 → | Jan 20, 2016, 7:19 pm EST | Mark KaufmannChief Financial Officer | 686 | $13.99 | $9,598 | 1,282 | — | plan? late |
| Aug 18, 2015 SForm 4 → | Aug 27, 4:47 pm EDT | Michael RaabPresident & CEO, Director | 1,104 | $20.00 | $22,080 | 80,170 | −1.36% | plan? late |
| Aug 6, 2015 SForm 4 → | Aug 11, 3:56 pm EDT | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $19.07 | $38,140 | 46,666 | −4.11% | plan? late |
| Aug 6, 2015 MForm 4 → | Aug 11, 3:56 pm EDT | Jeffrey W JacobsSVP, Technical Operations | 2,000 | $0.54 | $1,080 | 48,666 | — | plan? late |
| Aug 3, 2015 SForm 4 → | Aug 4, 7:46 pm EDT | Michael RaabPresident & CEO, Director | 300 | $20.00 | $6,000 | 81,247 | −0.37% | plan? |
| Jul 30, 2015 SForm 4/A → | Sep 2, 5:12 pm EDT | David P. RosenbaumSVP, Drug Development | 2,011 | $19.27 | $38,755 | 25,880 | −7.21% | plan? |
| Jul 30, 2015 SForm 4 → | Aug 3, 7:53 pm EDT | David P. RosenbaumSVP, Drug Development | 2,011 | $19.27 | $38,755 | 75,581 | −2.59% | plan? amended |
| Jul 28, 2015 SForm 4 → | Jul 30, 5:23 pm EDT | Michael RaabPresident & CEO, Director | 2,111 | $20.00 | $42,220 | 81,547 | −2.52% | plan? |
| Jul 28, 2015 MSForm 4 → | Jul 29, 5:28 pm EDT | Jeffrey W JacobsSenior VP, Technical Ops | 5,000 | $10.27 | $51,350 | 46,666 | — | plan? |
| Jul 22, 2015 SForm 4 → | Jul 23, 5:02 pm EDT | Elizabeth A GrammerVP, General Counsel | 2,500 | $18.00 | $45,000 | 0 | −100% | plan? |
| Jul 22, 2015 MForm 4 → | Jul 23, 5:02 pm EDT | Elizabeth A GrammerVP, General Counsel | 2,500 | $1.08 | $2,700 | 2,500 | — | plan? |
| Jul 15, 2015 SForm 4 → | Jul 16, 5:13 pm EDT | Elizabeth A GrammerVP, General Counsel | 10,000 | $17.12 | $171,150 | 0 | −100% | plan? |
| Jul 15, 2015 MForm 4 → | Jul 16, 5:13 pm EDT | Elizabeth A GrammerVP, General Counsel | 5,000 | $0.54 | $2,700 | 10,000 | — | plan? |
| Jun 11, 2015 AForm 4 → | Jun 12, 6:33 pm EDT | David M MottDirector, 10% Owner | 5,821 | — | — | 5,821 | — | plan? |
| Jun 11, 2015 AForm 4 → | Jun 12, 6:29 pm EDT | Peter G SchultzDirector | 2,910 | — | — | 910,339 | — | plan? |
| Jun 11, 2015 AForm 4 → | Jun 12, 6:28 pm EDT | Richard J RodgersDirector | 4,554 | — | — | 4,554 | — | plan? |
| Jun 10, 2015 PForm 4 → | Jun 12, 6:29 pm EDT | Gordon RingoldDirector | 10,000 | $15.19 | $151,880 | 10,000 | — | plan? |
| Jun 5, 2015 PForm 4 → | Jun 9, 4:47 pm EDT | Peter J Barris10% Owner | 4,672,897 | $10.70 | $49,999,998 | 1,401,869 | — | plan? |
| Jun 5, 2015 PForm 4 → | Jun 9, 4:46 pm EDT | M James Barrett10% Owner | 1,869,159 | $10.70 | $20,000,001 | 7,488,893 | +33.3% | plan? |
| Jun 5, 2015 PForm 4 → | Jun 9, 4:46 pm EDT | Forest Baskett10% Owner | 4,672,897 | $10.70 | $49,999,998 | 1,401,869 | — | plan? |
| Jun 5, 2015 PForm 4 → | Jun 9, 4:46 pm EDT | Ryan D Drant10% Owner | 1,869,159 | $10.70 | $20,000,001 | 7,488,893 | +33.3% | plan? |
| Jun 5, 2015 PForm 4 → | Jun 9, 4:45 pm EDT | Patrick J Kerins10% Owner | 1,869,159 | $10.70 | $20,000,001 | 7,488,893 | +33.3% | plan? |
| Jun 5, 2015 PForm 4 → | Jun 9, 4:45 pm EDT | Scott D Sandell10% Owner | 4,672,897 | $10.70 | $49,999,998 | 1,401,869 | — | plan? |
| Jun 5, 2015 PForm 4 → | Jun 9, 4:42 pm EDT | Krishna Kittu Kolluri10% Owner | 4,672,897 | $10.70 | $49,999,998 | 1,401,869 | — | plan? |
| Jun 5, 2015 PForm 4 → | Jun 9, 4:41 pm EDT | David M MottDirector, 10% Owner | 2,803,738 | $10.70 | $29,999,997 | 1,401,869 | — | plan? |
| Jun 5, 2015 PForm 4 → | Jun 9, 4:41 pm EDT | New Enterprise Associates 12, Limited Partnership +210% Owner | 1,869,159 | $10.70 | $20,000,001 | 7,488,893 | +33.3% | plan? |
| Jun 5, 2015 PForm 4 → | Jun 8, 5:08 pm EDT | Peter G SchultzDirector | 46,729 | $10.70 | $500,000 | 907,429 | +5.43% | plan? |
| May 4, 2015 SForm 4 → | May 5, 8:14 pm EDT | Mark KaufmannChief Financial Officer | 9,083 | $10.81 | $98,232 | 596 | −93.8% | plan? |
| May 4, 2015 MForm 4 → | May 5, 8:14 pm EDT | Mark KaufmannChief Financial Officer | 9,083 | $0.54 | $4,905 | 9,679 | — | plan? |
| Apr 8, 2015 JForm 4 → | Apr 10, 4:22 pm EDT | CMEA Ventures VII LP +110% Owner | 400,000 | — | — | 70,990 | — | plan? |
| Apr 6, 2015 SForm 4 → | Apr 8, 5:31 pm EDT | Mark KaufmannChief Financial Officer | 7,681 | $12.80 | $98,331 | 596 | −92.8% | plan? |
| Apr 6, 2015 MForm 4 → | Apr 8, 5:31 pm EDT | Mark KaufmannChief Financial Officer | 7,681 | $0.54 | $4,148 | 8,277 | — | plan? |
| Mar 3, 2015 SForm 4 → | Mar 5, 7:25 pm EST | Mark KaufmannChief Financial Officer | 6,075 | $15.60 | $94,748 | 596 | −91.1% | plan? |
| Mar 3, 2015 MForm 4 → | Mar 5, 7:25 pm EST | Mark KaufmannChief Financial Officer | 6,075 | $0.54 | $3,281 | 6,671 | — | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 7:11 pm EST | Elizabeth A GrammerVP, General Counsel | 1,737 | $15.81 | $27,470 | 5,000 | −25.8% | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 7:11 pm EST | Jeffrey W JacobsVP, Chemistry | 981 | $15.81 | $15,513 | 46,666 | −2.06% | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 7:09 pm EST | George JueVP, Operations | 1,500 | $15.88 | $23,822 | 24,134 | −5.85% | plan? amended |
| Feb 4, 2015 SForm 4 → | Feb 6, 6:40 pm EST | Jeffrey W JacobsVP, Chemistry | 8,888 | $16.28 | $144,736 | 46,666 | −16.0% | plan? |
| Feb 4, 2015 MForm 4 → | Feb 6, 6:40 pm EST | Jeffrey W JacobsVP, Chemistry | 8,888 | $1.08 | $9,599 | 55,554 | — | plan? |
| Jan 30, 2015 SForm 4 → | Feb 3, 5:33 pm EST | CMEA Ventures VII LP +110% Owner | 170,000 | $27.37 | $4,652,900 | 80,990 | −67.7% | plan? |
| Jan 8, 2015 SForm 4 → | Jan 12, 5:50 pm EST | CMEA Ventures VII LP +110% Owner | 300,000 | $24.25 | $7,275,000 | 85,240 | −77.9% | plan? |
| Dec 30, 2014 JForm 4 → | Jan 2, 2015, 4:06 pm EST | CMEA Ventures VII LP +110% Owner | 400,000 | — | — | 92,740 | — | plan? |
| Dec 23, 2014 JForm 4 → | Mar 12, 2015, 7:32 pm EDT | Michael RaabPresident & CEO, Director | 27 | — | — | 27 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2015 MForm 4 → | Feb 6, 6:40 pm EST | Jeffrey W JacobsVP, Chemistry | 8,888 | — | — | 0 | — | |
| Jan 6, 2015 AForm 4 → | Jan 8, 7:13 pm EST | Michael RaabPresident & CEO, Director | 75,000 | — | — | 75,000 | — | |
| Jan 6, 2015 AForm 4 → | Jan 8, 7:12 pm EST | David P. RosenbaumSVP, Drug Development | 12,620 | — | — | 12,620 | — | |
| Jan 6, 2015 AForm 4 → | Jan 8, 7:11 pm EST | Elizabeth A GrammerVP, General Counsel | 11,450 | — | — | 11,450 | — | |
| Jan 6, 2015 AForm 4 → | Jan 8, 7:11 pm EST | George JueVP, Operations & Facilities | 4,000 | — | — | 4,000 | — | |
| Jan 6, 2015 AForm 4 → | Jan 8, 7:10 pm EST | Jeffrey W JacobsVP, Chemistry | 11,850 | — | — | 11,850 | — | |
| Jan 6, 2015 AForm 4 → | Jan 8, 7:10 pm EST | Jeremy S CaldwellEVP, Chief Scientific Officer | 15,000 | — | — | 15,000 | — | |
| Jan 6, 2015 AForm 4 → | Jan 8, 7:09 pm EST | Mark KaufmannChief Financial Officer | 23,700 | — | — | 23,700 | — |